{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:43:06Z","timestamp":1792687386086,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022274","name":"Daiichi Sankyo Europe GmbH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.medcli.2026.107518","type":"journal-article","created":{"date-parts":[[2026,6,28]],"date-time":"2026-06-28T17:51:28Z","timestamp":1782669088000},"page":"107518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-world dosing patterns and outcomes of edoxaban in patients with non-valvular atrial fibrillation and type 2 diabetes mellitus: A gender perspective study"],"prefix":"10.1016","volume":"166","author":[{"given":"Jos\u00e9 Mar\u00eda","family":"Fern\u00e1ndez Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Javier","family":"Carrasco-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Gonz\u00e1lez-Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Diez-Manglano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesc","family":"Formiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2026.107518_bib0120","article-title":"Atrial fibrillation: epidemiology, screening and digital health","volume":"37","author":"Linz","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/j.medcli.2026.107518_bib0125","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jacc.2019.07.020","article-title":"Atrial fibrillation and diabetes mellitus: JACC review topic of the week","volume":"74","author":"Wang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.medcli.2026.107518_bib0130","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the managements of cardiovascular diseases in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2026.107518_bib0135","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.3390\/jcm12082868","article-title":"Atrial fibrillation and diabetes mellitus: dangerous liaisons or innocent bystanders?","volume":"12","author":"Lorenzo-Almor\u00f3s","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.medcli.2026.107518_bib0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2026.107518_bib0145","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.recesp.2023.12.003","article-title":"Incidencia y predicci\u00f3n de hospitalizaci\u00f3n por insuficiencia card\u00edaca en pacientes con fibrilaci\u00f3n auricular: escala REFLEJA","volume":"77","author":"Torres-Llergo","year":"2024","journal-title":"Rev Esp Cardiol"},{"key":"10.1016\/j.medcli.2026.107518_bib0150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ijcard.2020.01.009","article-title":"Efficacy and safety of edoxaban in patients with diabetes mellitus in the ENGAGE AF-TIMI 48 trial","volume":"304","author":"Plitt","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.medcli.2026.107518_bib0155","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.medcli.2026.107518_bib0160","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12872-021-02019-0","article-title":"Demographic, clinical and functional determinant of antithrombotic treatment in patients with nonvalvular atrial fibrillation","volume":"21","author":"Mostaza","year":"2021","journal-title":"BMC Cardiovasv Disord"},{"key":"10.1016\/j.medcli.2026.107518_bib0165","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2026.107518_bib0170","unstructured":"European Medicines Agency (EMEA), product information. ema.europa.eu\/en\/documents\/product-information\/lixiana-epar-product-information_en.pdf. Consulted on December 2025."},{"key":"10.1016\/j.medcli.2026.107518_bib0235","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.rccl.2021.03.002","article-title":"Seguridad y efectividad del edoxab\u00e1n en la pr\u00e1ctica cl\u00ednica tras un a\u00f1o de seguimiento en Espa\u00f1a Registro ETNA-AF-EUROPE","volume":"57","author":"Bar\u00f3n-Esquivias","year":"2022","journal-title":"Rec CardioClin"},{"key":"10.1016\/j.medcli.2026.107518_bib0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108265","article-title":"Gender difference in association between diabetes mellitus and all-cause mortality in atrial fibrillation patients","volume":"36","author":"Tian","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.medcli.2026.107518_bib0185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0247097","article-title":"Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: a long-term real worlds data analysis","volume":"16","author":"Shiyovich","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2026.107518_bib0190","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1161\/CIRCULATIONAHA.120.052216","article-title":"Comparison of the efficacy and safety outcomes of edoxaban in 8040 women versus 13065 men with atrial fibrillation in the ENGAGE AF-TIMI 48 Trial","volume":"143","author":"Zelniker","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107518_bib0195","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.medcli.2026.107518_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.tru.2021.100070","article-title":"Edoxaban dosing patterns in real life practice \u2013 results from the DRESDEN NOAC REGISTRY","volume":"5","author":"Beyer-Westendorf","year":"2021","journal-title":"Thrombosis Update"},{"key":"10.1016\/j.medcli.2026.107518_bib0205","doi-asserted-by":"crossref","first-page":"2778","DOI":"10.1038\/s41598-024-51776-3","article-title":"Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry","volume":"14","author":"Guo","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.medcli.2026.107518_bib0210","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jamacardio.2024.1793","article-title":"Dose reduction of edoxaban in patients 80 years and older with atrial fibrillation post hoc analysis of the ENGAGE AF-TIMI 48 randomized clinical trial","volume":"9","author":"Zimerman","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.medcli.2026.107518_bib0215","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/CIRCULATIONAHA.116.022361","article-title":"Impact of renal function on outcomes with edoxaban in the engage AF-TIMI study","volume":"134","author":"Bohula","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.medcli.2026.107518_bib0220","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003432","article-title":"Efficacy and safety of edoxaban in elderly patients with atrial fibrillation in the ENGAGE AF-TIMI 48 Trial","volume":"5","author":"Kato","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.medcli.2026.107518_bib0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279297","article-title":"Clinical outcomes in patients with atrial fibrillation treated with DOACs in specialized anticoagulation center: critical appraisal of real-world data","volume":"18","author":"Moret","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.medcli.2026.107518_bib0230","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.rccl.2023.04.006","article-title":"Evoluci\u00f3n cl\u00ednica de los pacientes con FA y diabetes mellitus en la pandemia de COVID-19. Registro REFADI","volume":"58","author":"Bar\u00f3n Esquivias","year":"2023","journal-title":"CardioClinics"}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775326001685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:30:46Z","timestamp":1792686646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775326001685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":23,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0025775326001685"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107518","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world dosing patterns and outcomes of edoxaban in patients with non-valvular atrial fibrillation and type 2 diabetes mellitus: A gender perspective study","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2026.107518","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107518"}}